BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38182553)

  • 1. Hippocampal region avoidance in whole brain radiotherapy in brain metastases: For all or for some? A real-world feasibility report.
    Corrao G; Bergamaschi L; Eleonora Pierini V; Gaeta A; Volpe S; Pepa M; Zaffaroni M; Vincini MG; Fodor CI; Piperno G; Emiro F; Ferrari A; Gandini S; Cattani F; Orecchia R; Marvaso G; Jereczek-Fossa BA
    Tumori; 2024 Feb; 110(1):34-43. PubMed ID: 38182553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
    Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
    Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study.
    Mehta P; Janssen S; Fahlbusch FB; Schmid SM; Gebauer J; Cremers F; Ziemann C; Tartz M; Rades D
    BMC Cancer; 2020 Jun; 20(1):610. PubMed ID: 32605648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
    Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
    Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience.
    Awad R; Fogarty G; Hong A; Kelly P; Ng D; Santos D; Haydu L
    Radiat Oncol; 2013 Mar; 8():62. PubMed ID: 23497418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases.
    Lebow ES; Hwang WL; Zieminski S; Wang Y; Niemierko A; Mehan WA; Oh KS; Khandekar M; Willers H; Shih HA
    J Neurooncol; 2020 May; 148(1):81-88. PubMed ID: 32307637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for reduced radiation-induced toxicity using intensity-modulated arc therapy for whole-brain radiotherapy with hippocampal sparing.
    Pokhrel D; Sood S; Lominska C; Kumar P; Badkul R; Jiang H; Wang F
    J Appl Clin Med Phys; 2015 Sep; 16(5):131–141. PubMed ID: 26699321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer.
    Zhou L; Liu J; Xue J; Xu Y; Gong Y; Deng L; Wang S; Zhong R; Ding Z; Lu Y
    Radiat Oncol; 2014 May; 9():117. PubMed ID: 24884773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy.
    Harth S; Abo-Madyan Y; Zheng L; Siebenlist K; Herskind C; Wenz F; Giordano FA
    Radiother Oncol; 2013 Oct; 109(1):152-8. PubMed ID: 24100152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric-modulated arc therapy (VMAT) for whole brain radiotherapy: not only for hippocampal sparing, but also for reduction of dose to organs at risk.
    Sood S; Pokhrel D; McClinton C; Lominska C; Badkul R; Jiang H; Wang F
    Med Dosim; 2017 Winter; 42(4):375-383. PubMed ID: 28822604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of hippocampal avoidance whole brain radiation in patients with hippocampal involvement: Data from a prospective study.
    Lee G; Besse L; Lamba N; Hancox C; Usta I; Hacker F; Catalano P; Brown PD; Tanguturi S; Pashtan I; Phillips J; Haas-Kogan D; Alexander B; Cagney D; Aizer A
    Med Dosim; 2021 Spring; 46(1):21-28. PubMed ID: 32778521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy.
    Gondi V; Tolakanahalli R; Mehta MP; Tewatia D; Rowley H; Kuo JS; Khuntia D; Tomé WA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1244-52. PubMed ID: 20598457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer.
    Westover KD; Mendel JT; Dan T; Kumar K; Gao A; Pulipparacharuv S; Iyengar P; Nedzi L; Hannan R; Anderson J; Choe KS; Jiang W; Abdulrahman R; Rahimi A; Folkert M; Laine A; Presley C; Cullum CM; Choy H; Ahn C; Timmerman R
    Neuro Oncol; 2020 Dec; 22(12):1831-1839. PubMed ID: 32347302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy.
    Mahadevan A; Sampson C; LaRosa S; Floyd SR; Wong ET; Uhlmann EJ; Sengupta S; Kasper EM
    Radiat Oncol; 2015 Nov; 10():245. PubMed ID: 26611656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric evaluation of intensity-modulated radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for hippocampal-avoidance whole brain radiotherapy.
    Rong Y; Evans J; Xu-Welliver M; Pickett C; Jia G; Chen Q; Zuo L
    PLoS One; 2015; 10(4):e0126222. PubMed ID: 25894615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated contouring and planning pipeline for hippocampal-avoidant whole-brain radiotherapy.
    Feng CH; Cornell M; Moore KL; Karunamuni R; Seibert TM
    Radiat Oncol; 2020 Oct; 15(1):251. PubMed ID: 33126894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perihippocampal failure after hippocampal-avoidance whole-brain radiotherapy in cancer patients with brain metastases: Results of a retrospective analysis.
    Shieh LT; Lee SW; Chen CC; Ho YC; Wang YW; Ho SY
    Medicine (Baltimore); 2022 Apr; 101(14):e29144. PubMed ID: 35446298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
    Brown PD; Gondi V; Pugh S; Tome WA; Wefel JS; Armstrong TS; Bovi JA; Robinson C; Konski A; Khuntia D; Grosshans D; Benzinger TLS; Bruner D; Gilbert MR; Roberge D; Kundapur V; Devisetty K; Shah S; Usuki K; Anderson BM; Stea B; Yoon H; Li J; Laack NN; Kruser TJ; Chmura SJ; Shi W; Deshmukh S; Mehta MP; Kachnic LA;
    J Clin Oncol; 2020 Apr; 38(10):1019-1029. PubMed ID: 32058845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclined head position improves dose distribution during hippocampal-sparing whole brain radiotherapy using VMAT.
    Kim KS; Seo SJ; Lee J; Seok JY; Hong JW; Chung JB; Kim E; Choi N; Eom KY; Kim JS; Kim IA
    Strahlenther Onkol; 2016 Jul; 192(7):473-80. PubMed ID: 27221313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
    Gondi V; Pugh SL; Tome WA; Caine C; Corn B; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Shah S; Shi W; Wendland M; Kachnic L; Mehta MP
    J Clin Oncol; 2014 Dec; 32(34):3810-6. PubMed ID: 25349290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.